Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Depreciation and Depletion: 2010-2019

Historic Depreciation and Depletion for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Dec 2019 value amounting to $3,000.

  • EyePoint Pharmaceuticals' Depreciation and Depletion rose 110.00% to $3,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $60,000, marking a year-over-year decrease of 57.14%. This contributed to the annual value of $1.5 million for FY2024, which is 208.00% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Depreciation and Depletion of $3,000 as of Q4 2019, which was down 93.18% from $44,000 recorded in Q1 2019.
  • In the past 5 years, EyePoint Pharmaceuticals' Depreciation and Depletion registered a high of $84,000 during Q2 2018, and its lowest value of -$30,000 during Q4 2018.
  • For the 3-year period, EyePoint Pharmaceuticals' Depreciation and Depletion averaged around $32,900, with its median value being $41,000 (2017).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first soared by 550.00% in 2017, then plummeted by 168.18% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Depreciation and Depletion (Quarterly) stood at $30,000 in 2015, then fell by 13.33% to $26,000 in 2016, then soared by 69.23% to $44,000 in 2017, then crashed by 168.18% to -$30,000 in 2018, then soared by 110.00% to $3,000 in 2019.
  • Its Depreciation and Depletion stands at $3,000 for Q4 2019, versus $44,000 for Q1 2019 and -$30,000 for Q4 2018.